Geriatric depression and vascular diseases: what are the links?

BACKGROUND The term "vascular depression" has been proposed to describe a subset of depressive disorders that occurs in old age as a consequence of cerebrovascular disease. However, depression has been shown to result from other cardiovascular diseases such as coronary heart diseases, as well as to precipitate, worsen or precede vascular diseases. Depression also increases the likelihood of the incidence of vascular risk factors such as diabetes. AIMS To review clinical and epidemiological evidence linking geriatric depression and vascular diseases, and to discuss the potential mechanisms that could underlie this association. METHOD Systematic review of the literature of the last 5 years through Medline database search. RESULTS Papers report the following potential ways of association: (1) there is a direct influence of vascular disease, in particular, arteriosclerosis, on the incidence of depression; (2) depressive disorders have a direct impact on the cardiovascular system; (3) depression and vascular disease share either a common pathophysiological process or genetic determinants. DISCUSSION Depression can be understood as the direct consequence of brain damage in neurodegenerative disorders such as Parkinson's or Huntington's diseases. Similarly, vascular depression is mostly considered to be the consequence of microvascular lesions on prefrontal and subcortical regions. However, this functional neuroanatomical model offers no explanation for cases where depression has been shown to precede vascular diseases. Since cardiovascular diseases develop in a context of acquired environmental factors together with genetically determined disease, it may be postulated that geriatric depression could both result from brain lesions of vascular origin and also share some pathogenic or genetic determinants.

[1]  C. Nemeroff,et al.  Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. , 2001, The American journal of psychiatry.

[2]  P. Boutin,et al.  Islet-brain1/C-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease , 2003, Molecular Psychiatry.

[3]  C. Jones,et al.  Arterial endothelial function is impaired in treated depression , 2002, Heart.

[4]  Casey Crump,et al.  Cerebrovascular Disease and Evolution of Depressive Symptoms in the Cardiovascular Health Study , 2002, Stroke.

[5]  G. Breithardt,et al.  Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. , 1991, European heart journal.

[6]  C. Marra,et al.  Frequency, phenomenology and anatomical–clinical correlates of major post-stroke depression , 1999, British Journal of Psychiatry.

[7]  John T. O'Brien,et al.  White Matter Changes in Depression and Alzheimer's Disease: A Review of Magnetic Resonance Imaging Studies , 1996 .

[8]  H. Kraemer,et al.  A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[9]  J. Ormel,et al.  Depression in survivors of stroke: a community-based study of prevalence, risk factors and consequences , 1998, Social Psychiatry and Psychiatric Epidemiology.

[10]  C. Nemeroff,et al.  Exaggerated platelet reactivity in major depression. , 1996, The American journal of psychiatry.

[11]  D. C. Olivier,et al.  Affective disorders and mortality. A general population study. , 1987, Archives of general psychiatry.

[12]  C. Di Menza,et al.  VLDL receptor polymorphism, cognitive impairment, and dementia , 2001, Neurology.

[13]  M Ashtari,et al.  MRI signal hyperintensities in geriatric depression. , 1996, The American journal of psychiatry.

[14]  C. Mazure,et al.  Depression in late life: age of onset as marker of a subtype. , 1989, Journal of affective disorders.

[15]  A Jordan,et al.  Depression in Europe , 1999, British Journal of Psychiatry.

[16]  R. Califf,et al.  Depression and long-term mortality risk in patients with coronary artery disease. , 1996, The American journal of cardiology.

[17]  D. Charney,et al.  Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. , 1981, Archives of general psychiatry.

[18]  T. Tanigawa,et al.  Prospective study of depressive symptoms and risk of stroke among japanese. , 2001, Stroke.

[19]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[20]  Jong S. Kim Cytokines and adhesion molecules in stroke and related diseases , 1996, Journal of the Neurological Sciences.

[21]  R F Spetzler,et al.  Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. , 1986, Stroke.

[22]  M. Fava,et al.  Serum cholesterol and serotonergic function in major depressive disorder , 2003, Psychiatry Research.

[23]  J. Grace,et al.  Association of life events and psychosocial factors with early but not late onset depression in the elderly: implications for possible differences in aetiology , 2003, International journal of geriatric psychiatry.

[24]  A. Döring,et al.  Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men , 2003, Brain, Behavior, and Immunity.

[25]  Michael Sharpe,et al.  Depression after stroke and lesion location: a systematic review , 2000, The Lancet.

[26]  B. Tress,et al.  Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study , 1998, BMJ.

[27]  L. Lipsitz,et al.  The microvascular frontal-subcortical syndrome of aging , 2002, Neurobiology of Aging.

[28]  R. Jaenisch,et al.  Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. , 2001, Molecular endocrinology.

[29]  D. Bush,et al.  Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. , 2000, Archives of internal medicine.

[30]  Suzanne Corkin,et al.  Visual dysfunction in Alzheimer's disease: Relation to normal aging , 1991, Annals of neurology.

[31]  E. Sprague,et al.  The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. , 1977, Atherosclerosis.

[32]  J T O'Brien,et al.  Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. , 2000, The American journal of psychiatry.

[33]  P. Valonen,et al.  Use of psychotropic drugs and risk of myocardial infarction: a case-control study in Finnish farmers. , 1996, International journal of epidemiology.

[34]  R. Carney,et al.  Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. , 2000, Journal of psychosomatic research.

[35]  A. Beekman,et al.  Depression in later life: three etiologically different subgroups. , 2001, Journal of affective disorders.

[36]  G. Alexopoulos,et al.  Clinically defined vascular depression. , 1997, The American journal of psychiatry.

[37]  C. Schacky,et al.  n−3 Fatty acids and the prevention of coronary atherosclerosis , 2000 .

[38]  J. Lépine,et al.  Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients , 2002, Psychiatry Research.

[39]  H. Stassen,et al.  Mortality of patients with mood disorders: follow-up over 34-38 years. , 2002, Journal of affective disorders.

[40]  B. Pollock,et al.  Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. , 2000, Journal of clinical psychopharmacology.

[41]  R. Carney,et al.  Depression and Coronary Heart Disease in Women With Diabetes , 2003, Psychosomatic medicine.

[42]  B. Leonard,et al.  Depression, stress and immunological activation: the role of cytokines in depressive disorders. , 1998, Life sciences.

[43]  P. Amouyel,et al.  Interactions between Apolipoprotein E and Apolipoprotein(a) in Patients with Late-Onset Alzheimer Disease , 2000, Annals of Internal Medicine.

[44]  Phyllis K. Stein,et al.  Effects of Depression on QT Interval Variability After Myocardial Infarction , 2003, Psychosomatic medicine.

[45]  B. Pollock,et al.  Changes in cognitive functioning following treatment of late-life depression. , 2000, The American journal of psychiatry.

[46]  K. Krishnan,et al.  Subcortical hyperintensities on brain magnetic resonance imaging: A comparison between late age onset and early onset elderly depressed subjects , 1991, Neurobiology of Aging.

[47]  R. Carney,et al.  Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. , 2002, Journal of psychosomatic research.

[48]  D. Blazer,et al.  APOE ɛ4 and Low Cholesterol as Risks for Depression in a Biracial Elderly Community Sample , 2002 .

[49]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[50]  K. Freedland,et al.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.

[51]  C. Altar Neurotrophins and depression. , 1999, Trends in pharmacological sciences.

[52]  R. Rosenman,et al.  Coronary heart disease in the Western Collaborative Group Study , 1970 .

[53]  C. Anderson,et al.  Prevalence of Depression After Stroke: The Perth Community Stroke Study , 1995, British Journal of Psychiatry.

[54]  E. Welker,et al.  Spatial, temporal and subcellular localization of islet‐brain 1 (IB1), a homologue of JIP‐1, in mouse brain , 2000, The European journal of neuroscience.

[55]  C. Nemeroff,et al.  Are platelets the link between depression and ischemic heart disease? , 2000, American heart journal.

[56]  James R. MacFall,et al.  Localization of age-associated white matter hyperintensities in late-life depression , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[57]  A. Burns,et al.  Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression , 1998, Psychological Medicine.

[58]  D. Ford,et al.  Depression and Risk for Onset of Type II Diabetes: A prospective population-based study , 1996, Diabetes Care.

[59]  Irl B Hirsch,et al.  The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. , 2003, General hospital psychiatry.

[60]  G. Zubenko,et al.  Association of the APOE ε4 allele with clinical subtypes of late life depression , 1996, Biological Psychiatry.

[61]  H. Krumholz,et al.  Depression and Risk of Heart Failure Among the Elderly: A Prospective Community-Based Study , 2002, Psychosomatic medicine.

[62]  C. DeCarli,et al.  Midlife cardiovascular risk factors and brain morphology in identical older male twins , 1999, Neurology.

[63]  C. Kilts,et al.  Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. , 1984, Science.

[64]  D. Horrobin,et al.  Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A‐independent transacylase , 2001, Human psychopharmacology.

[65]  L. Kuller,et al.  Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. , 2000, Atherosclerosis.

[66]  Salvatore Giaquinto,et al.  Depression after stroke: an investigation through catamnesis. , 1997, The Journal of clinical psychiatry.

[67]  C. Lyketsos,et al.  A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of ‘vascular depression’ , 2001, International journal of geriatric psychiatry.

[68]  E H Cook,et al.  Primary Structure of the Human Platelet Serotonin 5‐HT2A Receptor: Identity with Frontal Cortex Serotonin 5‐HT2A Receptor , 1994, Journal of neurochemistry.

[69]  C. Dina,et al.  The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes , 2000, Nature Genetics.

[70]  F. Panza,et al.  Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[71]  J. Salonen,et al.  Hopelessness and Risk of Mortality and Incidence of Myocardial Infarction and Cancer , 1996, Psychosomatic medicine.

[72]  K. Nakashima,et al.  Lipoprotein(a) Phenotypes in Patients with Vascular Dementia , 2000, Dementia and Geriatric Cognitive Disorders.

[73]  R. Brand,et al.  Coronary heart disease in Western Collaborative Group Study. Final follow-up experience of 8 1/2 years. , 1975, JAMA.

[74]  K. Krishnan,et al.  Allelic differences in the serotonin transporter-linked polymorphic region in geriatric depression. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[75]  C. Coffey,et al.  Quantitative cerebral anatomy of the aging human brain , 1992, Neurology.

[76]  T. Kamarck,et al.  Depressive symptomatology and coronary heart disease in Type I diabetes mellitus: a study of possible mechanisms. , 2002, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[77]  L. Pike,et al.  Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. , 2002, Biochemistry.

[78]  K. Krishnan,et al.  Cerebrovascular disease and depression symptoms in the cardiovascular health study. , 1999, Stroke.

[79]  E. Vartiainen,et al.  High serum cholesterol and risk of suicide. , 2000, The American journal of psychiatry.

[80]  James A. Blumenthal,et al.  Depression, Heart Rate Variability, and Acute Myocardial Infarction , 2001, Circulation.

[81]  N. Schneiderman,et al.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. , 2003, JAMA.

[82]  Emmanuel Mignot,et al.  Future of genetics of mood disorders research , 2002, Biological Psychiatry.

[83]  L. Liscum,et al.  Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. , 1996, Journal of lipid research.

[84]  M Ashtari,et al.  Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. , 1999, The American journal of psychiatry.

[85]  P. Rabins,et al.  Phenomenological comparison of poststroke depression and functional depression. , 1986, The American journal of psychiatry.

[86]  A. Leaf,et al.  ω3 Fatty Acids and Cardiovascular Disease , 1998 .

[87]  R. Robinson,et al.  Are depressive symptoms nonspecific in patients with acute stroke? , 1991, The American journal of psychiatry.

[88]  John J. Campbell,et al.  Neuropsychiatric Significance of Subcortical Hyperintensity , 2001 .

[89]  E. Caine,et al.  Depression, Medical Illness, and Interleukin-1β in Older Cardiac Patients , 2001, International journal of psychiatry in medicine.

[90]  I. Skoog,et al.  The incidence of first-onset depression in a population followed from the age of 70 to 85 , 2001, Psychological Medicine.

[91]  A. Beekman,et al.  Review of community prevalence of depression in later life , 1999, British Journal of Psychiatry.

[92]  E. Eaker,et al.  Depressed Affect, Hopelessness, and the Risk of Ischemic Heart Disease in a Cohort of U.S. Adults , 1993, Epidemiology.

[93]  D. Swaab,et al.  Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. , 1994, Neuroendocrinology.

[94]  G L Wolf,et al.  Brain imaging abnormalities in mental disorders of late life. , 1990, Archives of neurology.

[95]  F. Boller,et al.  Apolipoprotein E ϵ4 Allele and Clinically Defined Vascular Depression , 2002 .

[96]  D. Ford,et al.  Depression is a risk factor for coronary artery disease in men: the precursors study. , 1998, Archives of internal medicine.

[97]  J. Lönnqvist,et al.  Association of low serum total cholesterol with major depression and suicide , 1999, British Journal of Psychiatry.

[98]  M. Fava,et al.  Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder. , 2002, Psychosomatics.

[99]  D. Horrobin Abnormal membrane concentrations of 20 and 22-carbon essential fatty acids: a common link between risk factors and coronary and peripheral vascular disease? , 1995, Prostaglandins, leukotrienes, and essential fatty acids.

[100]  B. Pollock,et al.  Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. , 1998, JAMA.

[101]  F. Post The Management and Nature of Depressive Illnesses in Late Life: A Follow-Through Study , 1972, British Journal of Psychiatry.

[102]  P. Videbech MRI findings in patients with affective disorder: a meta‐analysis , 1997, Acta psychiatrica Scandinavica.

[103]  C. Coffey,et al.  Leukoencephalopathy in elderly depressed patients referred for ECT , 1988, Biological Psychiatry.

[104]  D. Horrobin,et al.  Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. , 1998, Journal of affective disorders.

[105]  P. Vokonas,et al.  Prospective study of a self-report type A scale and risk of coronary heart disease: test of the MMPI-2 type A scale. , 1998, Circulation.

[106]  Yong-Ku Kim,et al.  Low serum cholesterol is correlated to suicidality in a Korean sample , 2002, Acta psychiatrica Scandinavica.

[107]  H. Shimizu,et al.  Depressive symptoms and occurrence of type 2 diabetes among Japanese men. , 1999, Diabetes care.

[108]  N. Frasure-smith,et al.  Depression and 18-month prognosis after myocardial infarction. , 1995, Circulation.

[109]  R. Baldwin,et al.  Subcortical Hyperintensities in Late-Life Depression: Acute Response to Treatment and Neuropsychological Impairment , 1997, International Psychogeriatrics.

[110]  G. Alexopoulos,et al.  Subtypes of cognitive impairment in depressed older adults. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[111]  A. Leaf,et al.  Omega-3 fatty acids and cardiovascular disease. , 2001, World review of nutrition and dietetics.

[112]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[113]  C. Reynolds,et al.  Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. , 2001, The American journal of psychiatry.

[114]  P. Burger,et al.  Subcortical arteriosclerotic encephalopathy: brain stem findings with MR imaging. , 1987, Radiology.

[115]  K. Asplund,et al.  Major Depression in Stroke Patients: A 3‐Year Longitudinal Study , 1993, Stroke.

[116]  C. A. de Mendonça Lima,et al.  Are personality disorders more frequent in early onset geriatric depression? , 1997, Journal of affective disorders.

[117]  C. Mehringer,et al.  Apolipoprotein-E and white-matter hyperintensities in late-life depression. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[118]  B L Miller,et al.  Cognition and white matter hyperintensities in older depressed patients. , 1996, The American journal of psychiatry.

[119]  J. Sweeney,et al.  Involutional melancholia revisited. , 1984, The American journal of psychiatry.

[120]  I. Hickie,et al.  Early and late onset depression in old age: different aetiologies, same phenomenology. , 2001, Journal of affective disorders.

[121]  E. Kraepelin Psychiatrie : ein Lehrbuch für Studi[e]rende und Aerzte , 1976 .

[122]  K. Krishnan,et al.  Neuroanatomical substrates of depression in the elderly , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[123]  R. Ramasubbu Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. , 2002, Medical hypotheses.

[124]  A. Hofman,et al.  Cerebral white matter lesions and depressive symptoms in elderly adults. , 2000, Archives of general psychiatry.

[125]  B. Pollock,et al.  Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease , 1997, Biological Psychiatry.

[126]  J. Bigger,et al.  Cardiovascular effects of fluoxetine in depressed patients with heart disease. , 1998, The American journal of psychiatry.

[127]  R. Crum,et al.  Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. , 1996, Circulation.

[128]  J. Lion Personality disorders : diagnosis and management , 1974 .

[129]  D. Bush,et al.  The Significance of Depression in Older Patients After Myocardial Infarction , 2002, Journal of the American Geriatrics Society.

[130]  Angela L. Lee,et al.  Stress and depression: possible links to neuron death in the hippocampus. , 2002, Bipolar disorders.

[131]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[132]  B. MacVicar,et al.  Potassium-dependent calcium influx in acutely isolated hippocampal astrocytes , 1994, Neuroscience.

[133]  G. Alexopoulos,et al.  'Vascular depression' hypothesis. , 1997, Archives of general psychiatry.

[134]  I. Ferrier,et al.  Structural and functional abnormalities in elderly patients clinically recovered from early- and late-onset depression , 1998, Biological Psychiatry.

[135]  R. Carney,et al.  Major depression and medication adherence in elderly patients with coronary artery disease. , 1995, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[136]  G. Alexopoulos "The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists? , 2001, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[137]  H. Meltzer,et al.  Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids , 1996 .

[138]  T. Iidaka,et al.  Signal hyperintensities on brain magnetic resonance imaging in elderly depressed patients. , 1996, European neurology.

[139]  E. Boerwinkle,et al.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.

[140]  G. Alexopoulos,et al.  Late-onset depression. , 1988, The Psychiatric clinics of North America.

[141]  K. Pfeiffer,et al.  Lipoprotein(a) as a strong indicator for cerebrovascular disease. , 1986, Stroke.

[142]  Frank Bellivier,et al.  Psychiatric genetics: search for phenotypes , 1998, Trends in Neurosciences.

[143]  S. Holroyd,et al.  Differences in geriatric psychiatry outpatients with early‐ vs late‐onset depression , 1997, International journal of geriatric psychiatry.

[144]  G. Alexopoulos,et al.  The course of geriatric depression with "reversible dementia": a controlled study. , 1993, The American journal of psychiatry.

[145]  A. Nouwen,et al.  A review of the relationship between depression and diabetes in adults: is there a link? , 2000, Diabetes care.

[146]  C. Tangen,et al.  Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans , 2000 .

[147]  Robert Barber,et al.  Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. , 2002, Archives of general psychiatry.

[148]  A. Thomas,et al.  Is apolipoprotein e4 associated with cognitive decline in depression? , 2001, International journal of geriatric psychiatry.

[149]  P. Zwanzger,et al.  Combined action of the ACE D- and the G-protein β3 T-allele in major depression: a possible link to cardiovascular disease? , 2002, Molecular Psychiatry.

[150]  G. Andersen,et al.  Incidence of post‐stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale , 1994, Acta psychiatrica Scandinavica.

[151]  C. Nemeroff,et al.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.

[152]  J. Blumenthal,et al.  Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. , 1999, Circulation.

[153]  A. J. Kumar,et al.  Cortical magnetic resonance imaging changes in elderly inpatients with major depression. , 1991, The American journal of psychiatry.

[154]  I. Hickie,et al.  Late-onset depression: genetic, vascular and clinical contributions , 2001, Psychological Medicine.

[155]  M. Mussolino,et al.  Symptoms of Depression as a Prospective Risk Factor for Stroke , 2000, Psychosomatic medicine.

[156]  Henry Brodaty,et al.  Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression—A longitudinal evaluation , 1997, Biological Psychiatry.

[157]  H. S. Davis,et al.  A Controlled Study , 1966 .

[158]  Alan J. Thomas,et al.  Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly , 2002, British Journal of Psychiatry.

[159]  P. Vanhoutte Platelet‐Derived Serotonin, the Endothelium, and Cardiovascular Disease , 1991, Journal of cardiovascular pharmacology.

[160]  B. Fagerberg,et al.  Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk. , 1996, American journal of hypertension.

[161]  J. Toole,et al.  The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. , 1997, Neuroepidemiology.

[162]  B L Miller,et al.  Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.

[163]  A. Schousboe,et al.  Localization and pharmacological characterization of voltage dependent calcium channels in cultured neocortical neurons , 2001, International Journal of Developmental Neuroscience.

[164]  K. Krishnan,et al.  Apolipoprotein E-ε4 frequency in geriatric depression , 1996, Biological Psychiatry.

[165]  I. Ferrier,et al.  A neuropathological study of vascular factors in late-life depression , 2001, Journal of neurology, neurosurgery, and psychiatry.

[166]  Svante B. Ross,et al.  Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets , 2005, Psychopharmacology.

[167]  R. Carney,et al.  Depression in patients with coronary heart disease. A 12-month follow-up. , 1996, General hospital psychiatry.

[168]  B. Penninx,et al.  Depression and cardiac mortality: results from a community-based longitudinal study. , 2001, Archives of general psychiatry.

[169]  K. Krishnan,et al.  MRI-defined vascular depression. , 1997, The American journal of psychiatry.

[170]  M. Rubenfire,et al.  Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. , 2001, The American journal of cardiology.

[171]  G. Alexopoulos,et al.  Geriatric depression: Age of onset and dementia , 1993, Biological Psychiatry.

[172]  D. Horrobin,et al.  Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.

[173]  R. Kikinis,et al.  White matter changes with normal aging , 1998, Neurology.